{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:20:03Z","timestamp":1774984803676,"version":"3.50.1"},"reference-count":107,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) is an infectious viral disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is known that infection with SARS-CoV-2 can lead to various autoimmune and autoinflammatory diseases. There are few reports in the literature on the association between SARS-CoV-2 and autoimmune diseases, and the number of reports has been increasing since 2020. Autoimmune diseases and SARS-CoV-2 infections are intertwined in several ways. Both conditions lead to immune-mediated tissue damage, the immune response is accompanied by the increased secretion of inflammatory cytokines and both conditions can be treated using immunomodulatory drugs. Patients with certain autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, cardiac sarcoidosis, idiopathic pulmonary fibrosis, autoimmune hepatitis, multiple sclerosis and others, are more susceptible to SARS-CoV-2 infection, either because of the active autoimmune disease or because of the medications used to treat it. Conversely, SARS-CoV-2 infection can also cause certain autoimmune diseases. In this paper, we describe the development of autoimmune diseases after COVID-19 and the recovery from COVID-19 in people with autoimmune diseases.<\/jats:p>","DOI":"10.3390\/life12111918","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T03:35:23Z","timestamp":1668742523000},"page":"1918","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A Review Pertaining to SARS-CoV-2 and Autoimmune Diseases: What Is the Connection?"],"prefix":"10.3390","volume":"12","author":[{"given":"Nina","family":"Kocivnik","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6283-4348","authenticated-orcid":false,"given":"Tomaz","family":"Velnar","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pediatrneurol.2022.06.010","article-title":"Post-COVID-19 Immune-Mediated Neurological Complications in Children: An Ambispective Study","volume":"136","author":"Saini","year":"2022","journal-title":"Pediatr. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/cup.14281","article-title":"Cutaneous lupus-erythematosus-like reaction arising after COVID-19 vaccination","volume":"49","author":"Rose","year":"2022","journal-title":"J. Cutan. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.wneu.2020.12.111","article-title":"Management of Neurosurgical Cases in a Tertiary Care Referral Hospital During the COVID-19 Pandemic: Lessons from a Middle-Income Country","volume":"148","author":"Deora","year":"2021","journal-title":"World Neurosurg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1111\/1462-2920.15302","article-title":"Immunology of COVID-19","volume":"22","year":"2020","journal-title":"Environ. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/postgradmedj-2020-138386","article-title":"SARS-CoV-2 and the pandemic of COVID-19","volume":"97","author":"Adil","year":"2021","journal-title":"Postgrad. Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"611318","DOI":"10.3389\/fimmu.2020.611318","article-title":"COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases","volume":"11","author":"Lakota","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.12998\/wjcc.v10.i15.4726","article-title":"Management of neurosurgical patients during coronavirus disease 2019 pandemics: The Ljubljana, Slovenia experience","volume":"10","author":"Velnar","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 Transmission and Pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Padmanabhan, P., Desikan, R., and Dixit, N.M. (2020). Targeting TMPRSS2 and Cathepsin B\/L together may be synergistic against SARS-CoV-2 infection. PLoS Comput. Biol., 16.","DOI":"10.26434\/chemrxiv.12213125"},{"key":"ref_13","first-page":"371","article-title":"How SARS-CoV-2 (COVID-19) spreads within infected hosts\u2014What we know so far","volume":"4","author":"Sanyal","year":"2020","journal-title":"Emerg. Top. Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.therap.2020.06.013","article-title":"Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review","volume":"75","author":"Grange","year":"2020","journal-title":"Therapies"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e22.00013","DOI":"10.2106\/JBJS.RVW.22.00013","article-title":"What Do We Need to Know About Musculoskeletal Manifestations of COVID-19?: A Systematic Review","volume":"10","author":"Pires","year":"2022","journal-title":"JBJS Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100177","DOI":"10.1016\/j.ssmqr.2022.100177","article-title":"Support amid uncertainty: Long COVID illness experiences and the role of online communities","volume":"2","author":"Russell","year":"2022","journal-title":"SSM-Qual. Res. Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1002\/jmv.28086","article-title":"What are the long-term holistic health consequences of COVID-19 among survivors? An umbrella systematic review","volume":"94","author":"Paterson","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejor.2022.05.035","article-title":"Pandemic portfolio choice","volume":"305","author":"Kraft","year":"2023","journal-title":"Eur. J. Oper. Res."},{"key":"ref_19","first-page":"284","article-title":"Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: A narrative review","volume":"18","author":"Capone","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_20","first-page":"16","article-title":"The pathogenesis of autoimmune diseases","volume":"235","author":"Lorenz","year":"2001","journal-title":"Scand. J. Clin. Lab. Investig. Suppl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: A comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"104102","DOI":"10.1016\/j.ebiom.2022.104102","article-title":"Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis","volume":"81","author":"Wu","year":"2022","journal-title":"eBioMedicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.coi.2013.10.014","article-title":"Organ-specific and systemic autoimmune diseases","volume":"25","author":"Lehuen","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00281-002-0113-z","article-title":"Are we ready to predict and prevent endocrine\/organ specific autoimmune diseases?","volume":"24","author":"Seissler","year":"2002","journal-title":"Springer Semin. Immunopathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1164\/rccm.202008-3265OC","article-title":"Tissue-Specific Immunopathology in Fatal COVID-19","volume":"203","author":"Dorward","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/art.41460","article-title":"Anti\u2013Neutrophil Extracellular Trap Antibodies and Impaired Neutrophil Extracellular Trap Degradation in Antiphospholipid Syndrome","volume":"72","author":"Zuo","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00296-022-05203-3","article-title":"New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: A case series and literature review","volume":"42","author":"Sagy","year":"2022","journal-title":"Rheumatol. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1007\/s10067-020-05376-x","article-title":"The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: New insights approach","volume":"39","author":"Najafi","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"790","DOI":"10.14309\/ajg.0000000000000610","article-title":"COVID-19 Disease with Positive Fecal and Negative Pharyngeal and Sputum Viral Tests","volume":"115","author":"Chen","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s10067-022-06273-1","article-title":"Social networks as education strategies for indigenous patients with rheumatoid arthritis during COVID-19 pandemic. Are they useful?","volume":"41","author":"Quintana","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"ref_35","first-page":"19","article-title":"Patogeneza reumatoidnog artritisa [Pathogenesis of rheumatoid arthritis]","volume":"61","author":"Mayer","year":"2014","journal-title":"Reumatizam"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100512","DOI":"10.1016\/j.lanepe.2022.100512","article-title":"SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis","volume":"22","author":"Gaetani","year":"2022","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.wco.0000169737.99040.31","article-title":"Pathogenesis of multiple sclerosis","volume":"18","author":"Prat","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cyto.2014.05.008","article-title":"Cerebrospinal fluid and serum cytokine profiling to detect immune control of infectious and inflammatory neurological and psychiatric diseases","volume":"69","author":"Maxeiner","year":"2014","journal-title":"Cytokine"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"do Prado, C.B., Emerick, G.S., Cevolani Pires, L.B., and Salaroli, L.B. (2022). Impact of long-term COVID on workers: A systematic review protocol. PLoS ONE, 17.","DOI":"10.1101\/2022.03.07.22272051"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","article-title":"Pathophysiology and mechanism of long COVID: A comprehensive review","volume":"54","author":"Chalon","year":"2022","journal-title":"Ann. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","article-title":"Autoimmune and inflammatory diseases following COVID-19","volume":"16","author":"Galeotti","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.arcmed.2021.03.012","article-title":"Emerging Roles of Coronavirus in Autoimmune Diseases","volume":"52","author":"Zhou","year":"2021","journal-title":"Arch. Med. Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Freire-de-Lima, L., Scovino, A.M., Barreto Menezes, C.C., Marques da Fonseca, L., Santos Dos Reis, J., Rodrigues da Costa Santos, M.A., Monteiro da Costa, K., Antonio do Nascimento Santos, C., Freire-de-Lima, C.G., and Morrot, A. (2021). Autoimmune Disorders & COVID-19. Medicines, 8.","DOI":"10.3390\/medicines8100055"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1212\/NXI.0000000000000781","article-title":"Guillain-Barr\u00e9 syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing","volume":"7","author":"Dalakas","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","article-title":"Guillain Barre syndrome associated with COVID-19 infection: A case report","volume":"76","author":"Sedaghat","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/1744666X.2013.811119","article-title":"Infectious and noninfectious triggers in Guillain-Barre syndrome","volume":"9","author":"Wakerley","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: Causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"103206","DOI":"10.1016\/j.autrev.2022.103206","article-title":"COVID-19 and the antiphospholipid syndrome","volume":"21","author":"Serrano","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/ijmm.2020.4659","article-title":"Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)","volume":"46","author":"Cavalli","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/art.41472","article-title":"Reality Check on Antiphospholipid Antibodies in COVID-19\u2013Associated Coagulopathy","volume":"73","author":"Gkrouzman","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0041-1728832","article-title":"COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?","volume":"48","author":"Favaloro","year":"2022","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"584241","DOI":"10.3389\/fimmu.2020.584241","article-title":"Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome","volume":"11","author":"Borghi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e22571","DOI":"10.1002\/jcla.22571","article-title":"The analysis of false prolongation of the activated partial thromboplastin time (activator: Silica): Interference of C-reactive protein","volume":"32","author":"Liu","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_60","first-page":"A3985","article-title":"Investigation of coagulation time: PT and APTT","volume":"156","author":"Ramakers","year":"2012","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/joim.13126","article-title":"High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: A link with hypercoagulability?","volume":"289","author":"Frere","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5662\/wjm.v12.i4.200","article-title":"COVID-19 disease and autoimmune disorders: A mutual pathway","volume":"12","author":"Saeed","year":"2022","journal-title":"World J. Methodol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0961203312460722","article-title":"Diagnosis of antiphospholipid syndrome in routine clinical practice","volume":"22","author":"Gardiner","year":"2013","journal-title":"Lupus"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJMc2013656","article-title":"Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with COVID-19","volume":"383","author":"Bowles","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/jth.14867","article-title":"Lupus anticoagulant is frequent in patients with COVID-19","volume":"18","author":"Harzallah","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e29919","DOI":"10.1002\/pbc.29919","article-title":"Common bone marrow signature in COVID-19-associated multisystem inflammatory syndrome in children: A first-wave small case series experience","volume":"69","author":"Scarselli","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.120.048360","article-title":"Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic","volume":"142","author":"Belhadjer","year":"2020","journal-title":"Circulation"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.12998\/wjcc.v8.i21.5250","article-title":"Cardiovascular impact of COVID-19 with a focus on children: A systematic review","volume":"8","year":"2020","journal-title":"World J. Clin. Cases"},{"key":"ref_72","first-page":"252","article-title":"Kawasaki-like disease and acute myocarditis in the SARS-CoV-2 pandemic\u2014Reports of three adolescents","volume":"21","author":"Vukomanovic","year":"2021","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Hromi\u0107-Jahjefendi\u0107, A., Barh, D., Ramalho Pinto, C.H., Gabriel Rodrigues Gomes, L., Pican\u00e7o Machado, J.L., Afolabi, O.O., Tiwari, S., Aljabali, A.A.A., Tambuwala, M.M., and Serrano-Aroca, \u00c1. (2022). Associations and Disease\u2013Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review. Viruses, 14.","DOI":"10.3390\/v14050910"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/22221751.2021.1884503","article-title":"COVID-19-associated cytokine storm syndrome and diagnostic principles: An old and new Issue","volume":"10","author":"Yongzhi","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_75","first-page":"531","article-title":"Cytokine nanosponges suppressing overactive macrophages and dampening systematic cytokine storm for the treatment of hemophagocytic lymphohistiocytosis","volume":"21","author":"Wang","year":"2022","journal-title":"Bioact. Mater."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2016.05.022","article-title":"Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis","volume":"85","author":"Yang","year":"2016","journal-title":"Cytokine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/INF.0000000000003689","article-title":"Overcoming COVID-19 Investigators. Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection","volume":"41","author":"Zambrano","year":"2022","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1126\/sciimmunol.abm5505","article-title":"Innate immunological pathways in COVID-19 pathogenesis","volume":"7","author":"Paludan","year":"2022","journal-title":"Sci. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","article-title":"SARS-CoV-2 and viral sepsis: Observations and hypotheses","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e20202486","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3389\/fimmu.2020.01606","article-title":"Deciphering the role of host genetics in susceptibility to severe COVID-19","volume":"11","author":"Jorgensen","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"eabh1516","DOI":"10.1126\/sciimmunol.abh1516","article-title":"Polyclonal expansion of TCR Vbeta 21.3(+) CD4(+) and CD8(+) T cells is a hallmark of multisystem inflammatory syndrome in children","volume":"6","author":"Moreews","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e25170","DOI":"10.1097\/MD.0000000000025170","article-title":"Hemophagocytic Lymphohistiocytosis in COVID-19: Case Reports of a Stepwise Approach","volume":"100","author":"Schnaubelt","year":"2021","journal-title":"Medicine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1007\/s10067-022-06234-8","article-title":"Campos LMMA. COVID-19 quarantine in adolescents with autoimmune rheumatic diseases: Mental health issues and life conditions","volume":"41","author":"Ihara","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"103985","DOI":"10.1016\/j.msard.2022.103985","article-title":"The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study","volume":"65","author":"Babtain","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00296-020-04676-4","article-title":"Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: Clinical characteristics of poor outcomes","volume":"40","author":"Montero","year":"2020","journal-title":"Rheumatol. Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"609198","DOI":"10.3389\/fimmu.2020.609198","article-title":"Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature","volume":"11","author":"Barcellini","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","article-title":"Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: A systematic review and meta-analysis","volume":"80","author":"Akiyama","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"102687","DOI":"10.1016\/j.jaut.2021.102687","article-title":"COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review","volume":"123","author":"Bakasis","year":"2021","journal-title":"J. Autoimmun."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Voiriot, G., Philippot, Q., Elabbadi, A., Elbim, C., Chalumeau, M., and Fartoukh, M. (2019). Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients. J. Clin. Med., 8.","DOI":"10.3390\/jcm8060786"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41375-020-0848-3","article-title":"Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: A systematic review and meta-analysis","volume":"34","author":"Li","year":"2020","journal-title":"Leukemia"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Ibrahim, A., Ahmed, M., Conway, R., and Carey, J.J. (2018). Risk of Infection with Methotrexate Therapy in Inflammatory Diseases: A Systematic Review and Meta-Analysis. J. Clin. Med., 8.","DOI":"10.3390\/jcm8010015"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/annrheumdis-2020-217566","article-title":"Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine","volume":"79","author":"Mathian","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1136\/annrheumdis-2020-217794","article-title":"Patients with lupus with COVID-19: University of Michigan experience","volume":"80","author":"Wallace","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/annrheumdis-2020-217690","article-title":"COVID-19 Global Rheumatology Alliance. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19","volume":"79","author":"Konig","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: Data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"106239","DOI":"10.1016\/j.ijantimicag.2020.106239","article-title":"Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes","volume":"57","author":"Gautret","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/jm0601856","article-title":"Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities","volume":"49","author":"Biot","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08916930701619169","article-title":"Autoantibodies in type 1 diabetes","volume":"41","author":"Taplin","year":"2008","journal-title":"Autoimmunity"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1530\/EC-17-0347","article-title":"On type 1 diabetes mellitus pathogenesis","volume":"7","author":"Paschou","year":"2018","journal-title":"Endocr. Connect."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Deng, S.-Q., and Peng, H.-J. (2020). Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020575"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/11\/1918\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:20:47Z","timestamp":1760145647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/11\/1918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":107,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["life12111918"],"URL":"https:\/\/doi.org\/10.3390\/life12111918","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]}}}